Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Port site metastases.

Abhay Rané1, Michael K Eng, Francis X Keeley

  • 1East Surrey Hospital, Redhill, Surrey, UK. a.rane@btinternet.com

Current Opinion in Urology
|February 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A registry-based modified IDEAL stage 2b evaluation of urological procedures performed using the versius robotic surgical system.

Journal of robotic surgery·2025
Same author

Risk Factors for Residual Unablated Tumour Following CT-Guided Percutaneous Renal Cryoablation: Lessons from the EuRECA Registry.

Cardiovascular and interventional radiology·2025
Same author

Corrigendum to "The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data".

European urology focus·2024
Same author

The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs.

Minerva urology and nephrology·2024
Same author

The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data.

European urology focus·2024
Same author

Focused UTUC pathways with a risk-stratified approach to diagnostic ureteroscopy: is it the need of the hour? A retrospective cohort analysis.

World journal of urology·2024
Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026
Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026
Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026
Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026
Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026
Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026
See all related articles

Port site metastases after uro-oncological procedures are rare. Adhering to oncological surgery principles minimizes the risk of port site seeding, with ongoing research into tumoricidal instillations.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Port site metastases are a potential complication of minimally invasive oncological surgery.
  • Understanding their incidence and risk factors is crucial for patient outcomes.

Purpose of the Study:

  • To review the incidence, pathophysiology, and risk factors of port site metastases in uro-oncological procedures.
  • To explore methods for reducing the risk of port site metastases.

Main Methods:

  • Literature review of reported cases of port site metastasis in urologic procedures.
  • Analysis of current strategies to mitigate metastasis risk.

Main Results:

  • Twenty-eight cases of port site metastasis have been documented in the urologic literature.

Related Experiment Videos

  • Intraperitoneal instillation of tumoricidal agents is being investigated to prevent port site seeding.

    • Conclusions:

    • The risk of port site metastases is low when oncological surgical principles are strictly followed.
    • Vigilance and adherence to surgical best practices are key to minimizing this complication.